Financial Partners Capital Management’s AbbVie ABBV Stock Holding History

Financial Partners Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$539K	Hold	3,336	–	–	0.12%	93
2022 Q3	$448K	Hold	3,336	–	–	0.11%	99
2022 Q2	$511K	Hold	3,336	–	–	0.11%	101
2022 Q1	$541K	Sell	3,336 -316	-9%	-$45.9K	0.1%	98
2021 Q4	$494K	Hold	3,652	–	–	0.09%	96
2021 Q3	$394K	Sell	3,652 -20	-0.5%	-$2.29K	0.07%	96
2021 Q2	$414K	Hold	3,672	–	–	0.08%	92
2021 Q1	$397K	Buy	3,672 +1,432	+64%	+$153K	0.08%	88
2020 Q4	$240K	Buy	+2,240	New	+$215K	0.05%	94
2020 Q3	–	Sell	-2,344	Closed	-$230K	–	104
2020 Q2	$230K	Buy	+2,344	New	+$206K	0.07%	89
2018 Q4	–	Sell	-2,322	Closed	-$220K	–	80
2018 Q3	$220K	Sell	2,322 -70	-3%	-$6.64K	0.06%	77
2018 Q2	$222K	Hold	2,392	–	–	0.07%	74
2018 Q1	$226K	Hold	2,392	–	–	0.07%	71
2017 Q4	$231K	Sell	2,392 -100	-4%	-$9.43K	0.04%	116
2017 Q3	$221K	Buy	+2,492	New	+$190K	0.04%	113
2015 Q3	–	Sell	-3,198	Closed	-$215K	–	117
2015 Q2	$215K	Buy	+3,198	New	+$209K	0.05%	110
2015 Q1	–	Sell	-3,323	Closed	-$217K	–	111
2014 Q4	$217K	Sell	3,323 -542	-14%	-$34.2K	0.06%	106
2014 Q3	$223K	Hold	3,865	–	–	0.06%	101
2014 Q2	$218K	Buy	+3,865	New	+$203K	0.07%	103
2014 Q1	–	Sell	-3,865	Closed	-$204K	–	110
2013 Q4	$204K	Sell	3,865 -800	-17%	-$39.3K	0.07%	101
2013 Q3	$209K	Sell	4,665 -2,900	-38%	-$129K	0.08%	88
2013 Q2	$313K	Buy	+7,565	New	+$331K	0.14%	77

Other funds holding ABBV

AWA

Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Financial Partners Capital Management's ABBV Position: Q4 2022 in Review

Financial Partners Capital Management held its AbbVie (ABBV) position steady in Q4 2022 at 3,336 shares worth $539K. The position accounts for 0.12% of the portfolio, ranked #93.

Financial Partners Capital Management first reported a position in ABBV in Q2 2013 and has held it in 22 quarters since. The position peaked at $541K in Q1 2022. 3,167 funds tracked by Wall St. Rank hold ABBV as of Q4 2022.

Financial Partners Capital Management held 3,336 shares of AbbVie worth $539K as of Q4 2022.
Financial Partners Capital Management left its AbbVie share count unchanged in Q4 2022.
AbbVie made up 0.12% of Financial Partners Capital Management's portfolio in Q4 2022, its #93 holding.
Financial Partners Capital Management first reported a position in AbbVie in Q2 2013 and has held it in 22 quarters since.
Financial Partners Capital Management's AbbVie position peaked at $541K in Q1 2022.
3,167 funds tracked by Wall St. Rank held AbbVie as of Q4 2022.

Based on Financial Partners Capital Management's 13F filing for Q4 2022, filed 13 Feb 2023.